Market Closed -
Other stock markets
|
Pre-market 07:50:01 pm | |||
128.7 USD | -0.49% | 130.5 | +1.43% |
May. 14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
May. 13 | Merck: phase 3 trial in melanoma halted | CF |
Official Publications
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
Acquisition | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Dividends | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 10Q-2 | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Shareholders meeting voting results | CO | |
Dividends | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Official Publications